Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

The VITAL Trial: Phase II Trial of V osaroxin and I nfusional Cytarabine for Frontline T reatment of a cute Myeloid L eukemia

Stephen A Strickland, MD MSCI, Nikolai A. Podoltsev, MD PhD, Sanjay R Mohan, MD MSCI, Amer M. Zeidan, MBBS, MHS, Merrida A Childress, PhD, Gregory D Ayers, MS, Michael T Byrne, DO, Steven D. Gore, MD, Robert K. Stuart, MD, Michael R. Savona, MD

Blood (2019) 134 (Supplement_1): 180.

https://doi.org/10.1182/blood-2019-131520

Published: 2019

Journal Articles

Safety and Efficacy of Non-Irradiated Granulocyte Transfusions (GTX) in Neutropenic Patients with Severe or Refractory Abdominal Infections: A Single Center Retrospective Analysis of 119 Transfusions in 22 Patients

Guillaume Richard-Carpentier, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Tapan M. Kadia, MD, Gautam Borthakur, MD, Guillermo Garcia-Manero, MD, Courtney D. DiNardo, MD MSc, William G. Wierda, MD PhD, Naval G. Daver, MD, Naveen Pemmaraju, MD, Prithviraj Bose, MD, Marina Y. Konopleva, MD PhD, Michael Andreeff, MD PhD, Srdan Verstovsek, MD PhD, Heidi M Krause, Fleur M. Aung, MD, Jorge E. Cortes, MD

Blood (2018) 132 (Supplement 1): 3815.

https://doi.org/10.1182/blood-2018-99-119702

Published: 2018

Journal Articles

Predictors of Mortality in Neutropenic Enterocolitis Among Children and Young Adults with Acute Myeloid Leukemia in Low Middle Income Countries

Reham Khedr, MD, Mohamed Abdel Waged, Marwa Fathy, MD, Wael Zekri, MD

Blood (2018) 132 (Supplement 1): 5174.

https://doi.org/10.1182/blood-2018-99-114970

Published: 2018

Journal Articles

Updated Results from a Phase 1 Study of Gilteritinib in Combination with Induction and Consolidation Chemotherapy in Subjects with Newly Diagnosed Acute Myeloid Leukemia (AML)

Keith W. Pratz, MD, Mohamad Cherry, MDMS, Jessica K. Altman, MD, Brenda Cooper, MD, Jose Carlos Cruz, MD, Joseph G. Jurcic, MD, Mark J. Levis, MD, Tara L Lin, MD, Alexander E. Perl, MD, Nikolai A. Podoltsev, MD PhD, Gary J. Schiller, MD, Chaofeng Liu, PhD MBA, Erkut Bahceci, MD

Blood (2018) 132 (Supplement 1): 564.

https://doi.org/10.1182/blood-2018-99-110975

Published: 2018

Journal Articles

Economic Analysis of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Undergoing Remission Induction Chemotherapy from a Hospital Management Perspective

Elif G Umit, MD, Mehmet Baysal, MD, Onur Kirkizlar, Ahmet Muzaffer Demir, MD

Blood (2017) 130 (Supplement 1): 2126.

https://doi.org/10.1182/blood.V130.Suppl_1.2126.2126

Published: 2017

Journal Articles

A Randomized Placebo-Controlled Phase II Study of Clarithromycin or Placebo Combined with VCD Induction Therapy Prior to High-Dose Melphalan with Stem Cell Support in Patients with Newly Diagnosed Multiple Myeloma

Henrik Gregersen, MD, Niels Abildgaard, MD, Trung Hieu Do, MD, Ida Bruun Kristensen, MD, Ulf Christian Frølund, MD, Niels Frost Andersen, MD, Lene Kongsgaard Nielsen, MD, Christen Lykkegaard Andersen, MD, Tobias Wirenfeldt Klausen, M.S., Annette Juul Vangsted, MD

Blood (2017) 130 (Supplement 1): 3129.

https://doi.org/10.1182/blood.V130.Suppl_1.3129.3129

Published: 2017

Journal Articles

Phase II Trial of Vosaroxin and Infusional Cytarabine for Frontline Treatment of Acute Myeloid Leukemia (VITAL) Patients Eligible for Intensive Chemotherapy: A Planned Interim Analysis

Stephen A. Strickland, MD MSCI, Nikolai A. Podoltsev, MD PhD, Sanjay R. Mohan, MD MSCI, Amer M. Zeidan, MD, Gregory D. Ayers, MS, Molly Olson, MS, Steven D. Gore, MD, Robert K. Stuart, MD, Michael R. Savona, MD

Blood (2017) 130 (Supplement 1): 2630.

https://doi.org/10.1182/blood.V130.Suppl_1.2630.2630

Published: 2017

Journal Articles

Tigecycline-Based Front-Line Antibiotic Therapy Significantly Decreases Mortality Among Patients with Neutropenic Enterocolitis Following Cytarabine-Containing Chemotherapy for the Remission Induction of Acute Myeloid Leukemia

Pugliese Novella, Paola Salvatore, MD, Dora Vita Iula, MD, Maria Rosaria Catania, MD, Federico Chiurazzi, MD, Marta Raimondo, Giuliana Beneduce, Claudio Cerchione, Roberta Della Pepa, Claudia Giordano, MD, Luigia Simeone, MD, Fabrizio Pane, MD, Marco Picardi

Blood (2016) 128 (22): 3550.

https://doi.org/10.1182/blood.V128.22.3550.3550

Published: 2016

Journal Articles

Neutropenic enterocolitis in adults with hematological malignancy afte intensive cheMotherapy

Xie Yaping, Xilian Huang, Pengfei Shi, Kuang Chen, MD, Daquan Gao, Shenxian Qian, MD

Blood (2014) 124 (21): 5977.

https://doi.org/10.1182/blood.V124.21.5977.5977

Published: 2014

Journal Articles

Neutropenic Enterocolitis: Clinical Features and Outcomes

Delphine Lebon, MD, Emmanuel Canet, MD, Lucie Biard, MD, David Schnell, MD, Camille Roussel, Sophie Buyse, Benoit Schlemmer, MD PhD, Elie Azoulay, MD PhD

Blood (2014) 124 (21): 5984.

https://doi.org/10.1182/blood.V124.21.5984.5984

Published: 2014

Journal Articles

Neutropenic Enterocolitis in Adult Patients with Acute Leukemia: A Single Center Experience

Reena K. Vora, MD, Marc Braunstein, MD, Jae Cho, MD, Martin L. Lesser, PhD, Eran Ben-Levi, MD, Thomas P. Bradley, MD, Steven L. Allen, MD, Jonathan E. Kolitz, MD

Blood (2012) 120 (21): 4324.

https://doi.org/10.1182/blood.V120.21.4324.4324

Published: 2012

Journal Articles

How I treat hematologic emergencies in adults with acute leukemia

Tsila Zuckerman, Chezi Ganzel, Martin S. Tallman, Jacob M. Rowe

Blood (2012) 120 (10): 1993–2002.

https://doi.org/10.1182/blood-2012-04-424440

Published: 2012

Journal Articles

Use of Biosimilar G-CSF Is Effective After Autologous Bone Marrow Transplantation

Katarzyna Kotwica, MD, Maria B. Cioch, MD, Malgorzata Wach, MD, PhD, Joanna Manko, MD, Dariusz Jawniak, MD, Adam Walter-Croneck, MD, Wojciech Legiec, MD, Anna Dmoszynska

Blood (2011) 118 (21): 5321.

https://doi.org/10.1182/blood.V118.21.5321.5321

Published: 2011

Journal Articles

Favorable Outcomes of Neutropenic Enterocolitis Following Hematopoietic Stem Cell Transplantation (HSCT) Using a Conservative Medical Therapy Approach.

Antonio M. Jimenez, MD, George Behrens, MD, John Maciejewski, MD, PhD, Norman Wool, MD, Elizabeth Shima Rich, MD, PhD, Reem Karmali, MD, Parameswaran Venugopal, MD, Stephanie A. Gregory, MD, Henry C. Fung, FRCP, MD, Sunita Nathan, MD

Blood (2010) 116 (21): 1283.

https://doi.org/10.1182/blood.V116.21.1283.1283

Published: 2010

Journal Articles

Early Diagnosis of Neutropenic Enterocolitis by Ultrasound Sonography.

Edoardo Benedetti, Federico Simonetti, MD, Francesco Caracciolo, Federico Papineschi, Benedetto Bruno, MD, PhD, Matteo Pelosini, Daniele Focosi, M.D., Sara Galimberti, Mario Petrini, MD

Blood (2009) 114 (22): 4742.

https://doi.org/10.1182/blood.V114.22.4742.4742

Published: 2009

Journal Articles

Incidence and Risk Factors for Lower Alimentary Tract Mucositis (neutropenic enterocolitis) Following 1528 Courses of Chemotherapy in a Homogenous Population of Myeloma Patients: Clinical and Research Implications.

Somashekar G Krishna, MD, MPH, Zhao Weizhi, Kavya Krishna, MD, Monica Grazziutti, MD, Bart Barlogie, MD, PhD, Elias Anaissie, MD

Blood (2009) 114 (22): 3343.

https://doi.org/10.1182/blood.V114.22.3343.3343

Published: 2009

NARROW

The VITAL Trial: Phase II Trial of V osaroxin and I nfusional Cytarabine for Frontline T reatment of a cute Myeloid L eukemia

Safety and Efficacy of Non-Irradiated Granulocyte Transfusions (GTX) in Neutropenic Patients with Severe or Refractory Abdominal Infections: A Single Center Retrospective Analysis of 119 Transfusions in 22 Patients

Predictors of Mortality in Neutropenic Enterocolitis Among Children and Young Adults with Acute Myeloid Leukemia in Low Middle Income Countries

Updated Results from a Phase 1 Study of Gilteritinib in Combination with Induction and Consolidation Chemotherapy in Subjects with Newly Diagnosed Acute Myeloid Leukemia (AML)

Economic Analysis of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Undergoing Remission Induction Chemotherapy from a Hospital Management Perspective

A Randomized Placebo-Controlled Phase II Study of Clarithromycin or Placebo Combined with VCD Induction Therapy Prior to High-Dose Melphalan with Stem Cell Support in Patients with Newly Diagnosed Multiple Myeloma

Phase II Trial of Vosaroxin and Infusional Cytarabine for Frontline Treatment of Acute Myeloid Leukemia (VITAL) Patients Eligible for Intensive Chemotherapy: A Planned Interim Analysis

Tigecycline-Based Front-Line Antibiotic Therapy Significantly Decreases Mortality Among Patients with Neutropenic Enterocolitis Following Cytarabine-Containing Chemotherapy for the Remission Induction of Acute Myeloid Leukemia

Neutropenic enterocolitis in adults with hematological malignancy afte intensive cheMotherapy

Neutropenic Enterocolitis: Clinical Features and Outcomes

Neutropenic Enterocolitis in Adult Patients with Acute Leukemia: A Single Center Experience

How I treat hematologic emergencies in adults with acute leukemia

Use of Biosimilar G-CSF Is Effective After Autologous Bone Marrow Transplantation

Favorable Outcomes of Neutropenic Enterocolitis Following Hematopoietic Stem Cell Transplantation (HSCT) Using a Conservative Medical Therapy Approach.

Early Diagnosis of Neutropenic Enterocolitis by Ultrasound Sonography.

Incidence and Risk Factors for Lower Alimentary Tract Mucositis (neutropenic enterocolitis) Following 1528 Courses of Chemotherapy in a Homogenous Population of Myeloma Patients: Clinical and Research Implications.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only